Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Progress Software
PRGS
$1.66B
| $24.2M | 0.01% |
453,399
+20,265
| +5% | +$1.11M |
|
1502
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
| $24.1M | 0.01% |
191,225
-13,198
| -6% | -$1.55M |
|
1503
Freshworks
FRSH
$3.14B
| $24.1M | 0.01% |
1,321,132
+16,807
| +1% | +$348K |
|
1504
Werner Enterprises
WERN
$2.24B
| $24M | 0.01% |
614,433
+18,894
| +3% | +$753K |
|
1505
Axsome Therapeutics
AXSM
$11.2B
| $24M | 0.01% |
301,074
+5,373
| +2% | +$451K |
|
|
DMC
1506
Del Monte Corp
DMC
$1.41B
| $24M | 0.01% |
926,383
+86,760
| +10% | +$2.16M |
|
1507
Andersons Inc
ANDE
$2.41B
| $24M | 0.01% |
417,935
-265,998
| -39% | -$14.3M |
|
|
AGR
1508
DELISTED
Avangrid, Inc.
AGR
| $23.9M | 0.01% |
656,959
+47,982
| +8% | +$1.57M |
|
1509
Jack in the Box
JACK
$312M
| $23.9M | 0.01% |
349,118
+1,815
| +0.5% | +$137K |
|
1510
Rogers Corp
ROG
$2.21B
| $23.9M | 0.01% |
201,254
+7,662
| +4% | +$896K |
|
1511
Acushnet Holdings
GOLF
$5.93B
| $23.9M | 0.01% |
361,670
-660
| -0.2% | -$42.7K |
|
1512
Rapid7
RPD
$645M
| $23.8M | 0.01% |
485,604
+6,029
| +1% | +$331K |
|
1513
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.79B
| $23.8M | 0.01% |
410,059
-4,399,203
| -91% | -$239M |
|
1514
Fox Factory Holding Corp
FOXF
$755M
| $23.6M | 0.01% |
452,946
+31,943
| +8% | +$1.88M |
|
1515
Hillman Solutions
HLMN
$1.54B
| $23.6M | 0.01% |
2,215,814
+98,512
| +5% | +$920K |
|
1516
Weis Markets
WMK
$1.91B
| $23.6M | 0.01% |
366,087
+28,158
| +8% | +$1.76M |
|
|
KAMN
1517
DELISTED
Kaman Corp
KAMN
| $23.5M | 0.01% |
513,252
-24,894
| -5% | -$1.02M |
|
1518
Corcept Therapeutics
CORT
$12.4B
| $23.5M | 0.01% |
933,461
+33,017
| +4% | +$780K |
|
1519
Wabash National
WNC
$512M
| $23.5M | 0.01% |
784,619
-12,746
| -2% | -$336K |
|
1520
Remitly
RELY
$4.79B
| $23.4M | 0.01% |
1,129,682
+20,685
| +2% | +$393K |
|
1521
Impinj
PI
$4.62B
| $23.4M | 0.01% |
182,340
+1,493
| +0.8% | +$157K |
|
|
PGRE
1522
DELISTED
Paramount Group
PGRE
| $23.4M | 0.01% |
4,986,432
+230,207
| +5% | +$1.08M |
|
1523
Penske Automotive Group
PAG
$14.3B
| $23.2M | 0.01% |
143,038
+792
| +0.6% | +$121K |
|
1524
Sprout Social
SPT
$516M
| $23.2M | 0.01% |
387,760
-18,679
| -5% | -$1.13M |
|
1525
Hilltop Holdings
HTH
$2.26B
| $23.1M | 0.01% |
739,041
+37,955
| +5% | +$1.21M |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.